US strategy shift causes growth pains for Elixinol - Business News Australia
US strategy shift causes growth pains for Elixinol Business News Australia
One of Australia's leading medicinal cannabis companies saw 19 per cent year-on-year revenue growth for the first half of 2019, but the outcome would have ...
Comments
Post a Comment